Evidence map›Paper›PMID 40371913›Full record

ArticleBioanalysis2025

LC-MS/MS determination of trazodone in human plasma and its pharmacokinetic study in healthy Chinese.

Kaiwei Luo, Danrui Liu, Shengshuo Zhang, Xin Zhang, Qunan Cheng, Jie Lin, Yonghua Yu

Abstract read
In one paragraph

Article in Bioanalysis, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. PtNiSnOInternational journal of molecular sciences · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Kaiwei LuoFuan Pharmaceutical Group Ningbo Team Pharmaceutical Co., Ltd, Ningbo, China.
Danrui LiuFuan Pharmaceutical Group Ningbo Team Pharmaceutical Co., Ltd, Ningbo, China.
Shengshuo ZhangFuan Pharmaceutical Group Ningbo Team Pharmaceutical Co., Ltd, Ningbo, China.
Xin ZhangFuan Pharmaceutical Group Ningbo Team Pharmaceutical Co., Ltd, Ningbo, China.
Qunan ChengFuan Pharmaceutical Group Ningbo Team Pharmaceutical Co., Ltd, Ningbo, China.
Jie LinFuan Pharmaceutical Group Ningbo Team Pharmaceutical Co., Ltd, Ningbo, China.
Yonghua YuFuan Pharmaceutical Group Ningbo Team Pharmaceutical Co., Ltd, Ningbo, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsThis study aimed to establish a robust LC-MS/MS method for quantifying trazodone in human plasma and investigate its pharmacokinetic profile in healthy Chinese subjects under fasting and fed conditions. MATERIALS &

methodsA validated LC-MS/MS method using protein precipitation was applied to analyze trazodone in 68 healthy subjects (34 fasting/34 fed), with full method validation performed.

resultsThis method exhibited high selectivity, precision, and accuracy. The results showed good linearity in the range of 5-3000 ng/mL and matrix effect results showed no matrix interference. The pharmacokinetic data revealed notable differences between the fasting and postprandial states.

conclusionsThe validated LC-MS/MS method proved reliable for trazodone quantification. The observed food effects on absorption suggest clinical dosing should consider administration conditions to ensure optimal therapeutic outcomes.

Indexed as

Liquid Chromatography-Mass SpectrometryTrazodoneAdultChinaEast Asian PeopleFemaleHealthy VolunteersHumansMaleYoung AdultTrazodoneinternal standardisotopic trazodone-d6LC-MS/MSmethodology validationpharmacokineticTrazodone hydrochloride

Identifiers

PMID40371913
PMCPMC12160597

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.